ARAY - ACCURAY INC


0.4844
-0.006   -1.280%

Share volume: 539,600
Last Updated: 03-10-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$0.49
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
35%
Profitability 43%
Dept financing 44%
Liquidity 18%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
-1.20%
1 Month
-5.45%
3 Months
-55.96%
6 Months
-69.53%
1 Year
-73.38%
2 Year
-82.45%
Key data
Stock price
$0.48
P/E Ratio 
0.00
DAY RANGE
$0.48 - $0.50
EPS 
-$0.27
52 WEEK RANGE
$0.47 - $2.10
52 WEEK CHANGE
-$73.38
MARKET CAP 
93.461 M
YIELD 
N/A
SHARES OUTSTANDING 
118.783 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
3.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$854,302
AVERAGE 30 VOLUME 
$1,017,377
Company detail
CEO: Suzanne C. Winter
Region: US
Website: accuray.com
Employees: 1,040
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. The company also provides the TomoTherapy System, including the Radixact System.

Recent news